Concepedia

Juan-José Ortega

JO

Statistics

Publications

8

Citations

689

H-Index

8

Active since

1998

Affiliations

Hospital Universitari Germans Trias i Pujol(Current)

Institut Català d'Oncologia

Juan-José Ortega is an author at Hospital Universitari Germans Trias i Pujol specializing in oncology, medicine, and chemotherapy.

Publications per year

1998–2008

8

Publications

8

Comparison of the Results of the Treatment of Adolescents and Young Adults With Standard-Risk Acute Lymphoblastic Leukemia With the Programa Español de Tratamiento en Hematología Pediatric-Based Protocol ALL-96

Josep‐María Ribera, Albert Oriol, Miguel Á. Sanz et al. · Journal of Clinical Oncology · 2008 · 261 citations

, , +15

Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial.

Josep‐María Ribera, Albert Oriol, Concepción Bethencourt et al. · PubMed · 2005 · 168 citations

, , +14

Comparison of Intensive Chemotherapy, Allogeneic, or Autologous Stem-Cell Transplantation As Postremission Treatment for Children With Very High Risk Acute Lymphoblastic Leukemia: PETHEMA ALL-93 Trial

Josep‐María Ribera, Juan-José Ortega, Albert Oriol et al. · Journal of Clinical Oncology · 2006 · 55 citations

, , +17

Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology.

Josep‐María Ribera, Juan-José Ortega, Albert Oriol et al. · PubMed · 1998 · 48 citations

, , +12

Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.

Josep‐María Ribera, Juan-José Ortega, Albert Oriol et al. · PubMed · 2002 · 46 citations

, , +17

1–5 of 8